Extract notice to the Minister

NAT-Apixaban

Common name / Subject : apixaban
Name of the manufacturer : Natco
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on December 14, 2022

Subscribe to our newsletter now

Subscription